Advertisement

Survey and Summary of Results Obtained during the World-Wide Clinical Investigations of Adalat (Nifedipine)

  • F. Ebner

Abstract

Many experimental and clinical findings on Adalat have been reported in detail during this symposium. The different points of view on this new substance, its clinical efficacy, the mechanism of action and the tolerance have been discussed at length.

Keywords

Ischemic Heart Disease Peripheral Resistance Total Peripheral Resistance Facial Flush Left Ventr 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Angelino, P.F., Algranati, R., Tortore, P.: Hemodynamic studies. New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 221, 1975.Google Scholar
  2. 2.
    Bando, I.: pers. comm.Google Scholar
  3. 3.
    Camerini, F.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 260, 1975.Google Scholar
  4. 4.
    Caturelli, G.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 214, 1975.Google Scholar
  5. 5.
    Cherchi, A.: New Therapy of Ischemic Heart Disease, Adalat-Symp. Tokyo University press, 85, 1975.Google Scholar
  6. 6.
    Ebner, F., Braasch, W., Troll, V.: in press.Google Scholar
  7. 7.
    Ekelund, L. G.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 144, 1975.Google Scholar
  8. 8.
    Fleckenstein, A., Tritthart, H., Döring, H.-J., Byon, K.Y.: Arzneim.-Forsch. (Drug Res.) 22, Nr. 1, 22–32 (1972).Google Scholar
  9. 9.
    Fukozaki, H., Okamoto, R., Yokoyama, M., Tomomatsu, T.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 205, 1975.Google Scholar
  10. 10.
    Grün, G., Fleckenstein, A.: Arzneim.-Forsch. (Drug Res.) 22, Nr.2, 334–343 (1972).Google Scholar
  11. 11.
    Hayase, S., Hirakawa, S., Hosokawa, S., Mori, N., Kanyama, S., Iwasa, M: Arzneim.-Forsch. (Drug Res.) 22, Nr. 2, 370–373 (1972).Google Scholar
  12. 12.
    Hilger, H.H.:pers. comm.Google Scholar
  13. 13.
    Hirosawa, K., Hosada, S.: pers. comm.Google Scholar
  14. 14.
    Itoh, Y., Tawara, I., Itoh, T.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 251, 1975.Google Scholar
  15. 15.
    Jinnouchi, F., Mimura, G., Kodera, M.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 216, 1975.Google Scholar
  16. 16.
    Kaltenbach, M.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 126, 1975.Google Scholar
  17. 17.
    Kimura, E., Mabuchi, G., Kikuchi, H.: Arzneim.-Forsch. (Drug Res.) 22, Nr.2, 365–367 (1972).Google Scholar
  18. 18.
    Kobayashi, T., Ito, Y., Hawara, J.: Arzneim.-Forsch. (Drug Res.) 22, Nr.1, 380–389 (1972).Google Scholar
  19. 19.
    Kochsiek, K., Neubaur, J.: Arzneim.-Forsch. (Drug Res.) 22, Nr.2, 353–358 (1972).Google Scholar
  20. 20.
    Köhler, F. J.: II. Internat. Adalat-Symposion Amsterdam 1974, Springer Verlag, in press.Google Scholar
  21. 21.
    Kubicek, F.: Herz/Kreislauf 5, 9, 363–368 (1973).Google Scholar
  22. 22.
    Kuhns, K.: pers. comm.Google Scholar
  23. 23.
    Kurita, A., Kanazawa, M., Hamamoto, H.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 121, 1975.Google Scholar
  24. 24.
    Lang, E., Schoedel, J., Woike, N.: pers. comm.Google Scholar
  25. 25.
    Lemmerz, A. H.: pers. comm.Google Scholar
  26. 26.
    Lessmann, N., Schirmeister, J.: pers. comm.Google Scholar
  27. 27.
    Lichtlen, P.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 114, 1975.Google Scholar
  28. 28.
    Lydtin, H., Lohmöller, R., Walter, I.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 97, 1975.Google Scholar
  29. 29.
    Mabuchi, G., Kishida, H., Suzuki, K.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 177, 1975.Google Scholar
  30. 30.
    Maggi, G.C.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 160, 1975.Google Scholar
  31. 31.
    McIlwraith, G.: II. Internat. Adalat-Symposion Amsterdam, 1974, Springer Verlag, in press.Google Scholar
  32. 32.
    Menna, J., Traina, M., Cassera, J. C., Ferreiros, E., Rohwedder, R.: II. Internat. Adalat-Symposion Amsterdam, 1974, Springer Verlag, in press.Google Scholar
  33. 33.
    Mizuno, Y.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 163, 1975.Google Scholar
  34. 34.
    Nakamoto, K.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 279, 1975.Google Scholar
  35. 35.
    Niitani, H., Fujmaki, T.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 268, 1975.Google Scholar
  36. 36.
    Ogino, K.: pers. comm.Google Scholar
  37. 37.
    Redwood, D.R., Rosing, D.R., Goldstein, R.E., Beiser, G.D., Epstein, St. E.: Circul. Vol. XLIII, 618–628 (1971).CrossRefGoogle Scholar
  38. 38.
    Shibata, N.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 235, 1975.Google Scholar
  39. 39.
    Stein, G.: New Therapy of Ischemic Heart Diseases, Adalat-Symp. Tokyo University press, 192, 1975.Google Scholar
  40. 40.
    Stein, G.: II. Internat. Adalat-Symposion Amsterdam, 1974, Springer Verlag, in press.Google Scholar
  41. 41.
    Vater, W.: II. Internat. Adalat-Symposion Amsterdam, 1974, Springer Verlag, in press.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1975

Authors and Affiliations

  • F. Ebner
    • 1
  1. 1.Pharma-Forschungszentrum/Ressort MedizinBayer AGWuppertalFed. Rep. Germany

Personalised recommendations